535.41 5.35 (1.01%) | 05-03 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 631.69 | 1-year : | 650.34 |
Resists | First : | 540.83 | Second : | 556.79 |
Pivot price | 525.45 | |||
Supports | First : | 515 | Second : | 428.48 |
MAs | MA(5) : | 528.73 | MA(20) : | 529.26 |
MA(100) : | 519.55 | MA(250) : | 486.93 | |
MACD | MACD : | -1.9 | Signal : | -2.6 |
%K %D | K(14,3) : | 60.4 | D(3) : | 46.5 |
RSI | RSI(14): 54.3 | |||
52-week | High : | 558.34 | Low : | 424.22 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MDY ] has closed below upper band by 5.1%. Bollinger Bands are 24.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 541.02 - 543.1 | 543.1 - 545.18 |
Low: | 528.11 - 530.64 | 530.64 - 533.18 |
Close: | 531.33 - 535.16 | 535.16 - 538.98 |
The Trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the “Portfolio”), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index.
Thu, 02 May 2024
The 8 Best S&P 500 ETFs of May 2024 – Forbes Advisor - Forbes
Tue, 23 Apr 2024
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - TradingView
Tue, 16 Apr 2024
SPY: 10 Reasons To Believe A 10% Decline In The S&P 500 Is Forthcoming - Seeking Alpha
Fri, 15 Mar 2024
SPY ETF Update, 3/15/2024 - TipRanks.com - TipRanks
Fri, 23 Feb 2024
Should SPDR S&P 500 ETF (SPY) Be on Your Investing Radar? - Yahoo Finance
Fri, 16 Feb 2024
SPY vs. VOO: Which of Warren Buffett's ETFs Is Better? - Morningstar
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
AMEX
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |